Alkeus Pharmaceuticals INC
At a glance
EmployeesNot reported
In business sinceNot reported
HeadquartersCambridge, MA
SAM.gov UEIMQZNHQ1FW6M3
Alkeus Pharmaceuticals develops an oral investigational therapy designed to reduce vitamin A dimerization in the retina without modulating the visual cycle. The company is focused on treating retinal diseases, specifically Stargardt disease and geographic atrophy secondary to age-related macular degeneration, and is conducting clinical trials in these disease areas. No certifications are named in the text.
Summarized from the company’s own website
Their plant
| Facility | City | State | Employees | Status |
|---|---|---|---|---|
| Alkeus Pharmaceuticals INC | Cambridge | MA | — | ACTIVE |
Compiled from federal records — EPA, OSHA, SAM.gov and the U.S. Census — and from the company’s own website. Federal source data is public domain. Each plant’s page names the source of every field.